Seeking Alpha

Shares of Vivus (VVUS) are active in the post session on speculation that Johnson & Johnson...

Shares of Vivus (VVUS) are active in the post session on speculation that Johnson & Johnson (JNJ) and AstraZeneca (AZN) are considering a takeover of the drug developer due to the company's obesity drug Qsymia. Pfizer (PFE) may also take an interest should VVUS come under takeover attack, because obestity drugs are a hot item at present - with over 78M obese adults in the U.S. alone. Deal-watchers are skeptical however, noting that any deal with a chance of success would need to be in the $30-plus per share range. VVUS +1.3% AH.
Comments (1)
  • Year end. Wonder which large holder started this rumor?
    20 Dec 2012, 02:06 AM Reply Like
DJIA (DIA) S&P 500 (SPY)